Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TAK-442 in patients with arterial thrombosis
jRCT2080221100Phase 2
- Sponsor
- Takeda
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of letaxaban in arterial thrombosis, sponsored by Takeda.
02
Drugs
letaxaban
03
Conditions
arterial thrombosis
Beyond the preview
Go deeper on jRCT2080221100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221100.